Dr. Juan A. Escarfuller, MD

Dr. Escarfuller practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Escarfuller's NPI, 1962443127, was assigned on June 9, 2006. Dr. Escarfuller holds New York license 281318.

Dr. Escarfuller's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Escarfuller's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Escarfuller to 1 more group practice or clinic, 1 school health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Escarfuller practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Escarfuller's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Escarfuller's licenses on file in 2 states: New York and Louisiana.

CMS data shows 47 Medicare services from Dr. Escarfuller across 1 procedure code in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $6,119 for them. Every service was in an office.

CMS counts 37 Medicare patients who saw Dr. Escarfuller in 2024. The largest group is 75 to 84, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Escarfuller's median patient age at 66, with 49% women.

In 2024, Dr. Escarfuller wrote 1,504 Medicare Part D claims for 308 patients. 86% of them were for generic drugs. CMS names the drug for 1,292 of them, across 30 drugs with 11 or more claims each, at $166,317 in total drug cost. In 2023, CMS named 3,757 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Escarfuller for performance year 2024, reported as part of a group.

Dmand AI links 9 papers to Dr. Escarfuller, published from 2012 to 2021. 2019 was the busiest year, with 3. The most frequent topics are Parents, Hispanic or Latino and Pediatric Obesity. Dr. Escarfuller has published most often in Child Obes. Dr. Escarfuller's most frequent co-authors are Shari Lynn Barkin, MD, William John Heerman, MD and Jesse Cole, MD.

CMS Open Payments shows 117 general payments to Dr. Escarfuller from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $1,691.